PhenUtest Shortlisted for BioNow Start-Up Award 2023

PhenUtest Diagnostics is honoured to be shortlisted for the BioNow Start-Up Award 2023.

PhenUtest is developing a revolutionary urinary tract infection (UTI) diagnostic system that will diagnose a UTI and provide antimicrobial susceptibility test (AST) results within 60 minutes. UTIs are commonly seen in clinical practice and affect hundreds of millions of people per year worldwide, of which more than 71% are women.

Many thanks to BioNow for shortlisting PhenUtest as one of three inspiring start-up companies.